Christine Wyss
University of Zurich
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Christine Wyss.
Psychological Medicine | 2016
Michael Pascal Hengartner; Vladeta Ajdacic-Gross; Christine Wyss; Jules Angst; Wulf Rössler
BACKGROUND Mounting evidence supports the notion that personality is crucial in the aetiopathology of common mental disorders, but studies that allow for aetiological conclusions are lacking. The aim of the present study was thus to provide a test of the predisposition model. METHOD We analysed data from the Zurich Cohort Study, a 30-year longitudinal epidemiological community study of an adult cohort (n = 591) from 1979 to 2008. Personality was assessed in 1988 with an established personality questionnaire, and psychopathology through seven semi-structured interviews between 1979 and 2008. RESULTS On the basis of personality assessment from 1988, used as predictor of subsequent psychopathology (1993-2008), while adjusting for sex and prior mental disorders (1979-1988), neuroticism related significantly with future major depression episodes [odds ratio (OR) = 1.41], anxiety disorders (OR = 1.32) and depression treatment use (OR = 1.41). When participants with a past 10-year history (i.e. 1979-1988) of either major depression, anxiety disorder or depression treatment use were excluded, neuroticism in 1988 still significantly predicted first incidence (i.e. 1993-2008) of major depression episodes (OR = 1.53) and depression treatment use (OR = 1.84). CONCLUSIONS The present study provides compelling evidence that the personality trait of neuroticism constitutes an independent risk factor for subsequent major depression episodes and use of respective professional treatments, which serves as a proxy for particularly severe and impairing depression episodes. We therefore advocate that personality traits could provide clinically useful prognostic information when considered carefully.
PLOS ONE | 2013
Christine Wyss; Konrad Hitz; Michael Pascal Hengartner; Anastasia Theodoridou; Caitriona Obermann; Idun Uhl; Patrik Roser; Edna Grünblatt; Erich Seifritz; Georg Juckel; Wolfram Kawohl
Besides the influence of dopaminergic neurotransmission on negative symptoms in schizophrenia, there is evidence that alterations of serotonin (5-HT) system functioning also play a crucial role in the pathophysiology of these disabling symptoms. From post mortem and genetic studies on patients with negative symptoms a 5-HT dysfunction is documented. In addition atypical neuroleptics and some antidepressants improve negative symptoms via serotonergic action. So far no research has been done to directly clarify the association between the serotonergic functioning and the extent of negative symptoms. Therefore, we examined the status of brain 5-HT level in negative symptoms in schizophrenia by means of the loudness dependence of auditory evoked potentials (LDAEP). The LDAEP provides a well established and non-invasive in vivo marker of the central 5-HT activity. We investigated 13 patients with schizophrenia with predominant negative symptoms treated with atypical neuroleptics and 13 healthy age and gender matched controls with a 32-channel EEG. The LDAEP of the N1/P2 component was evaluated by dipole source analysis and single electrode estimation at Cz. Psychopathological parameters, nicotine use and medication were assessed to control for additional influencing factors. Schizophrenic patients showed significantly higher LDAEP in both hemispheres than controls. Furthermore, the LDAEP in the right hemisphere in patients was related to higher scores in scales assessing negative symptoms. A relationship with positive symptoms was not found. These data might suggest a diminished central serotonergic neurotransmission in patients with predominant negative symptoms.
European Archives of Psychiatry and Clinical Neuroscience | 2017
Nathalie Oexle; Nicolas Rüsch; Sandra Viering; Christine Wyss; Erich Seifritz; Ziyan Xu; Wolfram Kawohl
Mental illness stigma is a source of distress for persons with mental illness. Self-stigma occurs when negative stereotypes are internalized, leading to low self-esteem, shame and hopelessness. Due to its consequences self-stigma may contribute to suicidality and be a modifiable target for suicide prevention. Based on 222 disability pensioners with mental illness we examined whether self-stigma at baseline is associated with suicidal ideation over a 2-year period, controlling for baseline suicidal ideation, symptoms, age and gender. More self-stigma predicted suicidal ideation at baseline and longitudinally. Interventions on different levels to reduce self-stigma could improve suicide prevention.
PLOS ONE | 2014
Irene Neuner; Wolfram Kawohl; Jorge Arrubla; Tracy Warbrick; Konrad Hitz; Christine Wyss; Frank Boers; N. Jon Shah
Introduction Simultaneous recording of electroencephalography (EEG) and functional magnetic resonance imaging (fMRI) provides high spatial and temporal resolution. In this study we combined EEG and fMRI to investigate the structures involved in the processing of different sound pressure levels (SPLs). Methods EEG data were recorded simultaneously with fMRI from 16 healthy volunteers using MR compatible devices at 3 T. Tones with different SPLs were delivered to the volunteers and the N1/P2 amplitudes were included as covariates in the fMRI data analysis in order to compare the structures activated with high and low SPLs. Analysis of variance (ANOVA) and ROI analysis were also performed. Additionally, source localisation analysis was performed on the EEG data. Results The integration of averaged ERP parameters into the fMRI analysis showed an extended map of areas exhibiting covariation with the BOLD signal related to the auditory stimuli. The ANOVA and ROI analyses also revealed additional brain areas other than the primary auditory cortex (PAC) which were active with the auditory stimulation at different SPLs. The source localisation analyses showed additional sources apart from the PAC which were active with the high SPLs. Discussion The PAC and the insula play an important role in the processing of different SPLs. In the fMRI analysis, additional activation was found in the anterior cingulate cortex, opercular and orbito-frontal cortices with high SPLs. A strong response of the visual cortex was also found with the high SPLs, suggesting the presence of cross-modal effects.
NeuroImage | 2014
Christine Wyss; Frank Boers; Wolfram Kawohl; Jorge Arrubla; Kaveh Vahedipour; Jürgen Dammers; Irene Neuner; Nadim Joni Shah
Loudness dependence of auditory evoked potentials (LDAEP) evaluates loudness processing in the human auditory system and is often altered in patients with psychiatric disorders. Previous research has suggested that this measure may be used as an indicator of the central serotonergic system through the highly serotonergic innervation of the auditory cortex. However, differences among the commonly used analysis approaches (such as source analysis and single electrode estimation) may lead to different results. Putatively due to discrepancies of the underlying structures being measured. Therefore, it is important to learn more about how and where in the brain loudness variation is processed. We conducted a detailed investigation of the LDAEP generators and their temporal dynamics by means of multichannel magnetoencephalography (MEG). Evoked responses to brief tones of five different intensities were recorded from 19 healthy participants. We used magnetic field tomography in order to appropriately localize superficial as well as deep source generators of which we conducted a time series analysis. The results showed that apart from the auditory cortex other cortical sources exhibited activation during the N1/P2 time window. Analysis of time courses in the regions of interest revealed a sequential cortical activation from primary sensory areas, particularly the auditory and somatosensory cortex to posterior cingulate cortex (PCC) and to premotor cortex (PMC). The additional activation within the PCC and PMC has implications on the analysis approaches used in LDAEP research.
Psychiatry Research-neuroimaging | 2016
Sibylle Metzler; Diane Dvorsky; Christine Wyss; Carlos Nordt; Susanne Walitza; Karsten Heekeren; Wulf Rössler; Anastasia Theodoridou
An important aim in schizophrenia research is to optimize the prediction of psychosis and to improve strategies for early intervention. The objectives of this study were to explore neurocognitive performance in individuals at risk for psychosis and to optimize predictions through a combination of neurocognitive and psychopathological variables. Information on clinical outcomes after 24 months was available from 118 subjects who had completed an extensive assessment at baseline. Subjects who had converted to psychosis were compared with subjects who had not. Multivariate Cox regression analyses were used to determine which baseline measure best predicted a conversion to psychosis. The premorbid IQ and the neurocognitive domains of processing speed, learning/memory, working memory and verbal fluency significantly discriminated between converters and non-converters. When entered into multivariate regression analyses, the combination of PANSS positive/negative symptom severity and IQ best predicted the clinical outcomes. Our results confirm previous evidence suggesting moderate premorbid cognitive deficits in individuals developing full-blown psychosis. Overall, clinical symptoms appeared to be a more sensitive predictor than cognitive performance. Nevertheless, the two might serve as complementary predictors when assessing the risk for psychosis.
European Psychiatry | 2018
Alberto Del Guerra; S. Ahmad; Mihai Avram; Nicola Belcari; Arne Berneking; Laura Biagi; Maria Giuseppina Bisogni; Felix Brandl; Jorge Cabello; N. Camarlinghi; P. Cerello; Chang-Hoon Choi; S. Coli; Sabrina Colpo; Julien Fleury; Vito Gagliardi; Giuseppe Giraudo; Karsten Heekeren; Wolfram Kawohl; Theodora Kostou; Jean-Luc Lefaucheur; Christoph Lerche; George Loudos; M. Morrocchi; Julien Muller; Mona Mustafa; Irene Neuner; Panagiotis Papadimitroulas; Francesco Pennazio; Ravichandran Rajkumar
Simultaneous PET/MR/EEG (Positron Emission Tomography - Magnetic Resonance - Electroencephalography), a new tool for the investigation of neuronal networks in the human brain, is presented here within the framework of the European Union Project TRIMAGE. The trimodal, cost-effective PET/MR/EEG imaging tool makes use of cutting edge technology both in PET and in MR fields. A novel type of magnet (1.5T, non-cryogenic) has been built together with a PET scanner that makes use of the most advanced photodetectors (i.e., SiPM matrices), scintillators matrices (LYSO) and digital electronics. The combined PET/MR/EEG system is dedicated to brain imaging and has an inner diameter of 260 mm and an axial Field-of-View of 160 mm. It enables the acquisition and assessment of molecular metabolic information with high spatial and temporal resolution in a given brain simultaneously. The dopaminergic system and the glutamatergic system in schizophrenic patients are investigated via PET, the same physiological/pathophysiological conditions with regard to functional connectivity, via fMRI, and its electrophysiological signature via EEG. In addition to basic neuroscience questions addressing neurovascular-metabolic coupling, this new methodology lays the foundation for individual physiological and pathological fingerprints for a wide research field addressing healthy aging, gender effects, plasticity and different psychiatric and neurological diseases. The preliminary performances of two components of the imaging tool (PET and MR) are discussed. Initial results of the search of possible candidates for suitable schizophrenia biomarkers are also presented as obtained with PET/MR systems available to the collaboration.
Nervenarzt | 2017
Wolfram Kawohl; Christine Wyss; Patrik Roser; Martin Brüne; Wulf Rössler; Georg Juckel
ZusammenfassungHintergrundIn den letzten zwei Jahrzehnten hat die Ausbreitung der biologischen Psychiatrie stark zugenommen. Mit der Möglichkeit, das Gehirn mit modernen technischen Methoden zu erforschen, schien es, als ob die sozialen Einflussfaktoren bei der Entwicklung psychischer Krankheiten ihre Bedeutung verlieren würden. Tatsächlich scheint dies jedoch nicht gerechtfertigt zu sein. Es ist notwendig, diese Trennung zu überwinden, indem soziale Faktoren bei der Entwicklung psychischer Erkrankungen in einen konzeptuellen Rahmen eingebunden werden, der gleichzeitig auch die Ergebnisse der aktuellen neurobiologischen Forschung berücksichtigt.Ziele und MethodenDas Ziel dieser Übersichtsarbeit ist es, den aktuellen Stand der sozialpsychiatrischen Forschung zusammenzufassen und die Perspektive der biologischen Grundlagen und deren Stichhaltigkeit in Bezug auf die soziale Dimension der Psychiatrie am Beispiel schizophrener Störungen hervorzuheben. Der Beitrag zeigt Chancen auf für einen biosozialen Ansatz in der Sozialpsychiatrie und gibt einen Überblick über die aktuelle Literatur.Ergebnisse und DiskussionEs gibt eine Fülle neurobiologischer Forschungsansätze, die eng mit sozialpsychiatrischen Themen wie der sozialen Kognition verbunden sind. Sozialpsychiatrie und biologische Psychiatrie sollten nicht länger als diametral entgegengesetzte Subdisziplinen verstanden werden. Vielmehr müssen die Chancen, die aus einer Synthese entstehen können, in Forschung und Klinik genutzt werden.AbstractBackgroundThe proliferation of biological psychiatry has greatly increased over the last two decades. With the possibility to carry out brain research using modern technical methods, it seemed that social influencing factors would lose importance in the development of mental diseases; however, in actual fact this does not seem to be justified. It is necessary to overcome this separation, in that social factors are incorporated into a conceptual framework in the development of mental diseases, which simultaneously also takes the results of current neurobiological research into consideration.Objectives and MethodsThe aims of this review article are to summarize the current state of sociopsychiatric research and to emphasize the perspectives of the biological principles and their validity with respect to the social dimensions of psychiatry, as exemplified by schizophrenic disorders. The article presents the options for a biosocial approach in social psychiatry and gives an overview of the currently available literature.Results and ConclusionThere is an abundance of neurobiological research approaches, which are closely associated with sociopsychiatric topics, such as social cognition. Social psychiatry and biological psychiatry should no longer be considered as diametrically opposed subdisciplines. On the contrary, the options which could emerge from a synthesis must be used in research and clinical practice.BACKGROUND The proliferation of biological psychiatry has greatly increased over the last two decades. With the possibility to carry out brain research using modern technical methods, it seemed that social influencing factors would lose importance in the development of mental diseases; however, in actual fact this does not seem to be justified. It is necessary to overcome this separation, in that social factors are incorporated into a conceptual framework in the development of mental diseases, which simultaneously also takes the results of current neurobiological research into consideration. OBJECTIVES AND METHODS The aims of this review article are to summarize the current state of sociopsychiatric research and to emphasize the perspectives of the biological principles and their validity with respect to the social dimensions of psychiatry, as exemplified by schizophrenic disorders. The article presents the options for a biosocial approach in social psychiatry and gives an overview of the currently available literature. RESULTS AND CONCLUSION There is an abundance of neurobiological research approaches, which are closely associated with sociopsychiatric topics, such as social cognition. Social psychiatry and biological psychiatry should no longer be considered as diametrically opposed subdisciplines. On the contrary, the options which could emerge from a synthesis must be used in research and clinical practice.
Human Brain Mapping | 2017
Christine Wyss; Desmond H. Y. Tse; Michael Kometer; Jürgen Dammers; Rita Achermann; N. Jon Shah; Wolfram Kawohl; Irene Neuner
Gamma‐aminobutyric acid (GABA) and glutamate are believed to have inhibitory and exhibitory neuromodulatory effects that regulate the brains response to sensory perception. Furthermore, frequency‐specific synchronization of neuronal excitability within the gamma band (30–80 Hz) is attributable to a homeostatic balance between excitation and inhibition. However, our understanding of the physiological mechanism underlying gamma rhythms is based on animal models. Investigations of the relationship between GABA concentrations, glutamate concentrations, and gamma band activity in humans were mostly restricted to the visual cortex and are conflicting. Here, we performed a multimodal imaging study combining magnetic resonance spectroscopy (MRS) with electroencephalography (EEG) in the auditory cortex. In 14 healthy subjects, we investigated the impact of individual differences in GABA and glutamate concentration on gamma band response (GBR) following auditory stimulus presentation. We explored the effects of bulk GABA on the GBR across frequency (30–200 Hz) and time (−200 to 600 ms) and found no significant relationship. Furthermore, no correlations were found between gamma peak frequency or power measures and metabolite concentrations (GABA, glutamate, and GABA/glutamate ratio). These findings suggest that, according to MRS measurements, and given the auditory stimuli used in this study, GABA and glutamate concentrations are unlikely to play a significant role in the inhibitory and excitatory drive in the generation of gamma band activity in the auditory cortex. Hum Brain Mapp 38:3975–3987, 2017.
Nervenarzt | 2016
Wolfram Kawohl; Christine Wyss; Patrik Roser; Martin Brüne; Wulf Rössler; Georg Juckel
ZusammenfassungHintergrundIn den letzten zwei Jahrzehnten hat die Ausbreitung der biologischen Psychiatrie stark zugenommen. Mit der Möglichkeit, das Gehirn mit modernen technischen Methoden zu erforschen, schien es, als ob die sozialen Einflussfaktoren bei der Entwicklung psychischer Krankheiten ihre Bedeutung verlieren würden. Tatsächlich scheint dies jedoch nicht gerechtfertigt zu sein. Es ist notwendig, diese Trennung zu überwinden, indem soziale Faktoren bei der Entwicklung psychischer Erkrankungen in einen konzeptuellen Rahmen eingebunden werden, der gleichzeitig auch die Ergebnisse der aktuellen neurobiologischen Forschung berücksichtigt.Ziele und MethodenDas Ziel dieser Übersichtsarbeit ist es, den aktuellen Stand der sozialpsychiatrischen Forschung zusammenzufassen und die Perspektive der biologischen Grundlagen und deren Stichhaltigkeit in Bezug auf die soziale Dimension der Psychiatrie am Beispiel schizophrener Störungen hervorzuheben. Der Beitrag zeigt Chancen auf für einen biosozialen Ansatz in der Sozialpsychiatrie und gibt einen Überblick über die aktuelle Literatur.Ergebnisse und DiskussionEs gibt eine Fülle neurobiologischer Forschungsansätze, die eng mit sozialpsychiatrischen Themen wie der sozialen Kognition verbunden sind. Sozialpsychiatrie und biologische Psychiatrie sollten nicht länger als diametral entgegengesetzte Subdisziplinen verstanden werden. Vielmehr müssen die Chancen, die aus einer Synthese entstehen können, in Forschung und Klinik genutzt werden.AbstractBackgroundThe proliferation of biological psychiatry has greatly increased over the last two decades. With the possibility to carry out brain research using modern technical methods, it seemed that social influencing factors would lose importance in the development of mental diseases; however, in actual fact this does not seem to be justified. It is necessary to overcome this separation, in that social factors are incorporated into a conceptual framework in the development of mental diseases, which simultaneously also takes the results of current neurobiological research into consideration.Objectives and MethodsThe aims of this review article are to summarize the current state of sociopsychiatric research and to emphasize the perspectives of the biological principles and their validity with respect to the social dimensions of psychiatry, as exemplified by schizophrenic disorders. The article presents the options for a biosocial approach in social psychiatry and gives an overview of the currently available literature.Results and ConclusionThere is an abundance of neurobiological research approaches, which are closely associated with sociopsychiatric topics, such as social cognition. Social psychiatry and biological psychiatry should no longer be considered as diametrically opposed subdisciplines. On the contrary, the options which could emerge from a synthesis must be used in research and clinical practice.BACKGROUND The proliferation of biological psychiatry has greatly increased over the last two decades. With the possibility to carry out brain research using modern technical methods, it seemed that social influencing factors would lose importance in the development of mental diseases; however, in actual fact this does not seem to be justified. It is necessary to overcome this separation, in that social factors are incorporated into a conceptual framework in the development of mental diseases, which simultaneously also takes the results of current neurobiological research into consideration. OBJECTIVES AND METHODS The aims of this review article are to summarize the current state of sociopsychiatric research and to emphasize the perspectives of the biological principles and their validity with respect to the social dimensions of psychiatry, as exemplified by schizophrenic disorders. The article presents the options for a biosocial approach in social psychiatry and gives an overview of the currently available literature. RESULTS AND CONCLUSION There is an abundance of neurobiological research approaches, which are closely associated with sociopsychiatric topics, such as social cognition. Social psychiatry and biological psychiatry should no longer be considered as diametrically opposed subdisciplines. On the contrary, the options which could emerge from a synthesis must be used in research and clinical practice.